Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

cart

cart is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 16
Pipeline programs 61
News articles 0
Drug details — cart
Class
—
Route
—
Patents
16
Programs
61
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

cart is an FDA-listed pharmaceutical active ingredient.

Key facts

INN cart

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. Decartes-08 Phase 3 · Cartesian Therapeutics · Myasthaenia Gravis
  2. Instant MSC Product accompanying Autologous Chondron Transplantation (IMPACT) Phase 3 · Disc Medicine · Symptomatic articular cartilage lesion of the knee (femoral
  3. Microfracture Phase 3 · Hospital Authority · Other Articular Cartilage Disorders
  4. Placebo to Descartes-08, Descartes-08 Phase 3 · Cartesian Therapeutics · generalized myasthenia gravis
  5. cART(TDF/AZT+3TC+LPV/r) Phase 3 · Chinese Academy of · Acute HIV Infection
  6. ASCT+CD7-CART Phase 2 · Chinese Academy of · CD7 Positive
  7. Apheresis and Bridging Therapy Phase 2 · First People's Hospital · Large B-cell Lymphoma
  8. BCMA CART Phase 2 · Chinese Academy of · Ultra High Risk mm (uhr-mm), 18-70 Years Old, Suitable for A

Related patents

Browse patents

  1. US 11247974

    Small molecules that enable cartilage rejuvenation

    Expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11083758

    Placental membrane preparations and methods of making and using same for regenerating cartilage and spinal intervertebral discs

    Expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11072592

    Small molecules that enable cartilage rejuvenation

    Expires Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10940241

    Formation of stable cartilage

    Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10898497

    Compositions and methods for cartilage repair

    Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10869901

    Hydrolyzed chicken sternal cartilage extract, method for producing the same and use thereof

    Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10434188

    Hyaluronic acid binding domain-growth factor fusion protein cDNAs and fusion proteins for cartilage matrix preservation and repair

    Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9623151

    Biomaterials and implants for enhanced cartilage formation, and methods for making and using them

    Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9168261

    Compositions and methods for cartilage repair

    Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9133259

    Cartilage oligomeric matrix protein (COMP)—growth factor complexes and uses thereof

    Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9107883

    Compounds and methods for treating aberrant adrenocartical cell disorders

    Expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8299046

    Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth

    Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8202551

    Tissue engineered cartilage, method of making same, therapeutic and cosmetic surgical applications using same

    Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7476257

    Methods to engineer stratified cartilage tissue

    Expires Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 6855687

    Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor

    Expires Mon Feb 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6815416

    Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor

    Expires Mon Nov 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is cart?

cart is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.